News Articles for PharmAust

Anti cancer drug hopeful Pharmaust has appointed expert medical research company GenScript to take the trialling of their exciting anticancer drug PPL-1 to the next level. GenScript will trial the company's PPL-1 drug in animals in conjunction with standard care drugs that are usually prescribed for each particular type of cancer. The company is looking to ensure there is no adverse reaction when mixing their drug with others,

ASX listed Pharmaust is starting to look really interesting following the completion a “first in human trial” of its PPL-1 ant-cancer drug sometimes known as Monepantel.

New anti-cancer lab to lead the fight for anti-cancer drugs in Perth.

“First in man” anti-cancer drug trial shows promising results

Nedlands-based pharmaceutical company PharmAust has raised about $3.1 million in an oversubscribed placement to fund clinical trials for its cancer drug.

Bryant McLarty has resigned as a director and executive chairman of PharmAust.

Former biotechnology outfit PharmAust has flagged a rights issue as it expands into the oil and gas sector with a farm-in agreement over a two exploration permits near Sicily.

A group of dissident PharmAust Ltd shareholders forced the company to hold a formal poll after their push to replace the existing board was narrowly defeated on a show of hands at today's general meeting.

Nedlands-based pharmaceutical company PharmAust Ltd has reported a net loss of $2.5 million, up 103 per cent on the previous corresponding period's 1.2 million loss.

Nedlands-based pharmaceutical company PharmAust Ltd has signed a five-year distribution contract for five generic prescription medicines to the Australian market, the company announced today.

Nedlands-based pharmaceutical company PharmAust Ltd has secured approval from Australia's Therapeutic Goods Administration for its generic version of the cholesterol lowering drug Simavastatin.

A company behind businessman Michael Boyd will acquire a controlling stake in Balcatta-based pharmaceutical wholesaler Advance Healthcare Group, after Nedlands-based pharmaceutical company PharmAust Ltd withdrew its bid today.

BALCATTA-BASED Advance Healthcare Group Ltd will raise $400,000 through a share placement to fund legal action against a major shareholder, Nedlands-based PharmAust Ltd.

THE board of Advanced Health Care Group Ltd has advised shareholders to take no action in relation to a proposed takeover bid from Pharmaust and has labelled the move as “opportunistic”.

The board of Advanced Health Care Group Ltd has advised shareholders to take no action in relation to a proposed takeover bid from Pharmaust and has labelled the move as "opportunistic".

Advance Healthcare Group Ltd and dissident shareholder PharmAust have clashed again, even as they headed to mediation over litigation from an August meeting of AHG shareholders.

Australian Healthcare Group Ltd has announced that mediation in relation to litigation by PharmAust Ltd has been adjourned, but it remains confident that the matter can be resolved without going to trial.

Advance Healthcare Group Ltd has questioned claims by dissident shareholder PharmAust Ltd which made a surprise merger offer on Friday.

Nedlands-based pharmaceutical company PharmAust Ltd will take a 39.5 per cent stake in Nasdaq-listed US-based Commonwealth Biotechnologies Inc in exchange for its discovery chemistry subsidiary, Mimotopes Pty Ltd.

Nedlands-based pharmaceutical company PharmAust Ltd will raise $2.5 million for additional working capital through a share purchase plan and placement to eligible shareholders.

Nedlands-based pharmaceutical company PharmAust Ltd has signed manufacturing contracts with grocery chains IGA and New Zealand's Progressive Enterprises to produce a range of sun care and over-the-counter cough and cold products.

Nedlands-based pharmaceuticals company PharmAust Ltd has signed a 12 month contract with WA's Ganehill Pty Ltd to produce two new products in the Megan Gale Invisible Zinc Sun Care range.

Nedlands-based pharmaceutical group PharmAust Ltd has signed an agreement with US-based Commonwealth Biotechnologies Inc to co-market their products - giving both companies an entry into the other's markets.

Perth-based pharmaceutical group PharmAust Ltd has been granted a licence to manufacture medicinal products by the Therapeutic Goods Administration (TGA) and aims to register and manufacture 50 low cost generic medicines by 2008.

2,625,000 shares will be release from escrow on 1 December 2005.